过敏性鼻炎中的肠肺轴:微生物失生症和治疗策略
WeiKeng Yang1, Hui Wu2, Xiuyun Li3
1The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
Frontiers in microbiology
|December 29, 2025
概括
由减少酸盐和改变的肠道细菌标志着肠道失生症,与过敏性鼻炎 (AR) 有关. 微生物群干预措施对AR预防和管理有希望,特别是在儿童中.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 过敏性鼻炎 (AR) 影响全球10%-30%,造成严重的健康负担.
- 肠道微生物群的失衡可能会通过肠肺轴扰乱免疫调节,导致AR.
- 目前的临床应用落后于对AR的肠肺轴的研究见解.
研究的目的:
- 系统地审查AR中的肠道微生物群的免疫机制.
- 评估针对AR的微生物群向干预措施.
- 综合从临床,动物和多omics研究的发现.
主要方法:
- 从主要数据库 (PubMed,科学网等) 中对研究 (2010-2025) 的系统审查. ) 的情况.
- 包括临床研究,动物实验和多omics分析.
- 专注于免疫路径和与肠道微生物群和AR相关的治疗干预措施.
主要成果:
- 抗胰岛素患者表现出便丁酸盐降低和IgE升高,与肠道失生症有关 (例如,改变了Bacteroidetes/Firmicutes比率).
- 肠道失生症激活了基碳化合物受体 (AhR) 途径,并损害了调节性T细胞功能.
- 便微生物群移植 (FMT) 和益生菌 (例如,Clostridium butyricum) 在临床前和人体研究中显示出潜在的益处,降低IgE和IL-13水平.
结论:
- 肠道功能失调会破坏免疫代谢途径,导致AR的发展.
- 针对微生物群的干预措施为AR预防和管理提供了有希望的策略,特别是在儿科患者群体中.
- 包括饮食和减少空气污染在内的综合公共卫生战略对于长期的AR影响至关重要.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K


